BlossomHill Therapeutics, Inc.

Nasdaq: BLSMGrowth candidate

64 days public · Pharmaceutical Preparations · $17.48 (+3.55%)

Growth candidate RANKED

/ 100 fit

Confidence100%

BlossomHill Therapeutics, Inc. (BLSM) is a newly-public pharmaceutical preparations company trading at $17.48 with an intelligence score of 68 and a deterministic growth strategy-fit of 69 out of 100.

Intelligence score

/ 100 core

Suggested alloc

30%

cap · your limits

Days public

EARLY PUBLIC

Last price

$17.48

live quote

1d change

+3.55%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+Institutional ownership is strong with 4 Schedule 13D and 13G disclosures on file with the SEC, resulting in a high Institutional score of 93.
+Corporate narrative activity is robust with 3 Form 8-K filings and 22 insider forms registered with the SEC, yielding a Narrative score of 84.
+The company demonstrates positive near-term business momentum reflected by a 1-day price increase of 3.55% and a Momentum score of 57.

RisksLIVE